Skip to main content

Expanding Capabilities for Unapproved Cannabis-Derived Product Surveillance in the United States, TriNetX, July 1, 2018 – June 30, 2022

Basic Details
Date
Type
Presentation
Description

This poster explores the use of electronic health records (EHR) to identify exposures to unapproved cannabis-derived products (CDPs), including cannabidiol (CBD), as part of active safety surveillance efforts in the United States. It was presented at the 39th International Conference on Pharmacoepidemiology and Therapeutic Risk Management. 

Materials

Expanding Capabilities for Unapproved Cannabis-Derived Product Surveillance in the United States, TriNetX, July 1, 2018 – June 30, 2022

Information
Host

International Society for Pharmacoepidemiology

Related Assessment(s)
Characterization of Cannabis-Derived Product Users in TriNetX: Four Descriptive Analyses
Presenter(s)

Silvia Perez-Vilar, Sara Karami, Megan Wiley, Karen Long, Ashley I. Martinez, Kira Leishear, Meredith Epperson, Rose Radin, Patty Greene, Jana Mcaninch, Jillian Burk